(±)17(18)-EpETE-Ethanolamide
CAY-25920-25 25 µg
Synonyms:
17,18-EEQ-EA|(±)17(18)-EpETE-EA|(±)17,18-EEQ-Ethanolamide|17,18-epoxy-Eicosatetraenoic Acid Ethanolamide
Data Sheet: 
SDS:
SDS:
CAS
2123491-23-4
Formulation
A solution in ethanol
Purity
≥98%
MW
361,51824
Shipment
-20
Long Term Storage
-20
Shelf Life
730
Description
An ω-3 endocannabinoid epoxide; decreases LPS-induced IL-6 and nitrite production and increases the production of IL-10 in BV-2 microglia; inhibits arachidonic acid-induced platelet aggregation at 50 µM; induces relaxation of preconstricted bovine coronary arteries (ED50 = 1.1 µM); inhibits VEGF-stimulated tubulogenesis in HMVECs; activates CB1 and CB2 receptors (EC50s = 18.5 and 1.4 nM, respectively)
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
